Organon Investor Relations Material
Latest events
Q4 2023
Organon
Access the full event backlog
Slides, Transcripts, and Reports from 9,000+ public companies
Latest reports from Organon & Co
Access all reports
Segment Data
Access more data
Revenue by
Geography
Europe and Canada
U.S.
Asia Pacific and Japan
China
Other
Expenses by
Financials
Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. The company operates under the Organon & Co. Pharmaceuticals and Organon brands. Its products include hormone contraceptives; biosimilars; women's health products consisting of fertility, menopause, contraception, osteoporosis and gynecological cancer; and treatments for psychiatric and neurological disorders comprising schizophrenia, bipolar mania disorder and depression. The company also offers food animal health products, including pain relief for horses, cattle and sheep; and anti-infectives for poultry.
Key slides for Organon & Co
Q2 2023
Organon & Co
Q4 2023
Organon & Co
Latest articles
Daniel Ek: Co-founder and CEO of Spotify
Explore Daniel Ek's journey from a tech-savvy teenager to the co-founder and CEO of Spotify and the most influential person in the music industry.
28 Mar 2024
Companies That Had Their IPO in 1992: A Cautiously Optimistic Market
1992 marked a relatively cool IPO landscape and stock market sentiment, in the wake of the early 90s recession.
28 Mar 2024
Remembering Daniel Kahneman: Transforming Psychology and Economics
Explore Daniel Kahneman's legacy in psychology and economics, highlighting his impact on decision-making and behavioral economics.
28 Mar 2024
Ticker symbol
Country
🇺🇸 United States